Preoperative Radiotherapy and Chemotherapy for Rectal Cancer
Cancer Plus · 2020
DOI: 10.18063/cp.v2i3.363 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Plus, 2020. Verfasst von María Consuelo Figueroa und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
The objective of this study is to investigate the complete pathological reaction of preoperative radiotherapy and chemotherapy for rectal cancer. We conducted a retrospective and explanatory study to evaluate the reaction to preoperative radiotherapy and chemotherapy in 46 patients of stage I, II and III rectal adenocarcinoma from 2006 to 2014. These patients were divided into four groups, in which 52.17% complete remission (24 cases), 15.21% moderate remission (7 cases), 6.53% minimum remission (3 cases) and 26.09% adverse reactions (12 cases). In this study, more than 50% of patients with preoperative radiotherapy and chemotherapy show complete pathological response, which may provide the possibility for patients with rectal adenocarcinoma to receive this treatment in the future, and a carefully selected group among the patients will enter the observation period.
Zitieren
APA
Figueroa, M. C., Briceño, J. B., Puerta, D. L., Hurtado, W. D. V., Sánchez, N. O., Rodríguez, A. I., & Castillo, P. J. (2020). Preoperative Radiotherapy and Chemotherapy for Rectal Cancer. Cancer Plus. https://doi.org/10.18063/cp.v2i3.363
Vancouver
Figueroa MC, Briceño JB, Puerta DL, Hurtado WDV, Sánchez NO, Rodríguez AI, et al. Preoperative Radiotherapy and Chemotherapy for Rectal Cancer. Cancer Plus. 2020. doi:10.18063/cp.v2i3.363
BibTeX
@article{Figueroa2020,
author = {Figueroa, María Consuelo and Briceño, José B and Puerta, Dania L and Hurtado, Wendy Del Valle and Sánchez, Néstor O and Rodríguez, Antonio Ivo and Castillo, Pedro J},
title = {Preoperative Radiotherapy and Chemotherapy for Rectal Cancer},
journal = {Cancer Plus},
year = {2020},
doi = {10.18063/cp.v2i3.363}
}
EUVIMED